Peripheral blood cells are predominantly chimeric of affected and normal cells in patients with paroxysmal nocturnal hemoglobinuria: simultaneous investigation on clonality and expression of glycophosphatidylinositol-anchored proteins.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Blood

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1182/blood.v83.3.853.bloodjournal833853PMID 7507738
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Production and characterization of lymphoblastoid cell lines with the paroxysmal nocturnal hemoglobinuria phenotype.

  1993cited by this paper
• Clonal origin of abnormal granulocytes in paroxysmal nocturnal hemoglobinuria.

  1992cited by this paper
• Two distinct patterns of glycosylphosphatidylinositol (GPI) linked protein deficiency in the red cells of patients with paroxysmal nocturnal haemoglobinuria

  1992cited by this paper
• Remission induction of acute promyelocytic leukemia by all-trans-retinoic acid: molecular evidence of restoration of normal hematopoiesis after differentiation and subsequent extinction of leukemic clone.

  1992cited by this paper
• Clonal involvement of granulocytes and monocytes, but not of T and B lymphocytes and natural killer cells in patients with myelodysplasia: analysis by X-linked restriction fragment length polymorphisms and polymerase chain reaction of the phosphoglycerate kinase gene.

  1992cited by this paper
• Clonality in myeloproliferative disorders: analysis by means of the polymerase chain reaction.

  1991cited by this paper
• Clonal hematopoiesis in patients with acquired aplastic anemia.

  1991cited by this paper
• Acquired aplastic anemia and paroxysmal nocturnal hemoglobinuria: studies on clonality.

  1991cited by this paper
• Preferential expression of human Fc gamma RIIIPMN (CD16) in paroxysmal nocturnal hemoglobinuria. Discordant expression of glycosyl phosphatidylinositol-linked proteins.

  1991cited by this paper
• Clonality of cell populations in refractory anaemia using combined approach of gene loss and X‐linked restriction fragment length polymorphism‐methylation analyses

  1991cited by this paper
• Heterogenous expression of decay accelerating factor and CD59/membrane attack complex inhibition factor on paroxysmal nocturnal haemoglobinuria (PNH) erythrocytes

  1991cited by this paper
• Analysis of PI (phosphatidylinositol)‐anchoring antigens in a patient of paroxysmal nocturnal hemoglobinuria (PNH) reveals deficiency of 1F5 antigen (CD59), a new complement‐regulatory factor

  1990cited by this paper
• The PIG-anchoring defect in NK lymphocytes of PNH patients.

  1990cited by this paper
• Inherited complete deficiency of 20-kilodalton homologous restriction factor (CD59) as a cause of paroxysmal nocturnal hemoglobinuria.

  1990cited by this paper
• Deficiency of glycosyl-phosphatidylinositol-linked membrane glycoproteins of leukocytes in paroxysmal nocturnal hemoglobinuria, description of a new diagnostic cytofluorometric assay.

  1990cited by this paper
• Deficiency of glycosyl‐phosphatidylinositol anchored proteins on paroxysmal nocturnal haemoglobinuria (PNH) neutrophils and monocytes: heterogeneous deficiency of decay‐accelerating factor (DAF) and CD16 on PNH neutrophils

  1990cited by this paper
• A HIGHLY INFORMATIVE X‐CHROMOSOME PROBE, M27β, CAN BE USED FOR THE DETERMINATION OF TUMOUR CLONALITY

  1990cited by this paper
• Paroxysmal nocturnal hemoglobinuria.

  1989cited by this paper
• Clonal analysis of myelodysplastic syndromes: evidence of multipotent stem cell origin.

  1989cited by this paper
• A novel membrane glycoprotein capable of inhibiting membrane attack by homologous complement.

  1989cited by this paper
• Isolation from human erythrocytes of a new membrane protein which inhibits the formation of complement transmembrane channels.

  1988cited by this paper
• The major Fc receptor in blood has a phosphatidylinositol anchor and is deficient in paroxysmal nocturnal haemoglobinuria

  1988cited by this paper
• Clonal analysis using recombinant DNA probes from the X-chromosome.

  1987cited by this paper
• Deficiency of the homologous restriction factor in paroxysmal nocturnal hemoglobinuria

  1987cited by this paper
• Distribution of decay-accelerating factor in the peripheral blood of normal individuals and patients with paroxysmal nocturnal hemoglobinuria

  1985cited by this paper
• Complete purification of phosphatidylinositol-specific phospholipase C from a strain of Bacillus thuringiensis.

  1983cited by this paper
• Affected erythrocytes of patients with paroxysmal nocturnal hemoglobinuria are deficient in the complement regulatory protein, decay accelerating factor.

  1983cited by this paper
• [Paroxysmal nocturnal hemoglobinuria].

  1971cited by this paper
• Paroxysmal nocturnal hemoglobinuria: evidence for monoclonal origin of abnormal red cells.

  1970cited by this paper

• years show that minor mutant-positive clones can remain stable for many JAK2 V617F mutant levels in patients with essential thrombocythemia Long-term serial analysis of X-chromosome inactivation patterns and

  2013cites this paper
• infrequently in aplastic anemia Clonal hematopoiesis as defined by polymorphic X-linked loci occurs

  2011cites this paper
• and granulocytes cells, T cells, B cells, + Mitochondrial DNA spectra of single human CD34

  2011cites this paper
• Long-term serial analysis of X-chromosome inactivation patterns and JAK2 V617F mutant levels in patients with essential thrombocythemia show that minor mutant-positive clones can remain stable for many years.

  2007cites this paper
• Classification of chronic myeloid disorders: from Dameshek towards a semi-molecular system.

  2006cites this paper
• Long-term serial analysis of X-chromosome inactivation patterns and JAK 2 V 617 F mutant levels in patients with essential thrombocythemia show

  2006cites this paper
• Mitochondrial DNA spectra of single human CD34+ cells, T cells, B cells, and granulocytes.

  2005cites this paper
• Leukemic relapse in the central nervous system after allogeneic stem cell transplantation with complete remission in the bone marrow and donor‐type chimerism: Report of two cases

  2005cites this paper
• A New Aspect of the Molecular Pathogenesis of Paroxysmal Nocturnal Hemoglobinuria

  2002cites this paper
• The MAGE-A1 gene expression is not determined solely by methylation status of the promoter region in hematological malignancies.

  2002cites this paper
• Methylation status of the p15INK4B gene in hematopoietic progenitors and peripheral blood cells in myelodysplastic syndromes

  2000cites this paper
• Clonality analysis of refractory anemia with ring sideroblasts: simultaneous study of clonality and cytochemistry of bone marrow progenitors

  1999cites this paper
• Evaluation of clonality in myeloid stem-cell disorders.

  1999cites this paper
• Clonality analysis of granulocytes and T lymphocytes in healthy females by the PCR-based HUMARA method.

  1999cites this paper
• Hypermethylation of p15INK4B Gene in a Patient With Acute Myelogenous Leukemia Evolved From Paroxysmal Nocturnal Hemoglobinuria

  1998cites this paper
• Hypermethylation of p15(INK4B) gene in a patient with acute myelogenous leukemia evolved from paroxysmal nocturnal hemoglobinuria.

  1998cites this paper
• Paroxysmal nocturnal hemoglobinuria: new insights from murine Pig-a-deficient hematopoiesis.

  1997cites this paper
• [Erythropoietin: biochemical characteristics, biologic effects, indications and results of use in hematology].

  1997cites this paper
• Paroxysmal Nocturnal Hemoglobinuria as a Molecular Disease

  1997cites this paper
• Recent advances in paroxysmal nocturnal hemoglobinuria. From the biology to the clinic.

  1997cites this paper
• Clonality in hematopoietic disorders.

  1997cites this paper
• Role of phosphatidylinositol-linked proteins in paroxysmal nocturnal hemoglobinuria pathogenesis.

  1996cites this paper
• Recombinant human erythropoietin for long-term treatment of anemia in paroxysmal nocturnal hemoglobinuria.

  1996cites this paper
• Molecular basis of the heterogeneity of expression of glycosyl phosphatidylinositol anchored proteins in paroxysmal nocturnal hemoglobinuria.

  1996cites this paper
• A knock-out model of paroxysmal nocturnal hemoglobinuria: Pig-a(-) hematopoiesis is reconstituted following intercellular transfer of GPI-anchored proteins.

  1996cites this paper
• Analysis of the expression of glycosylphosphatidylinositol anchored proteins on platelets from patients with paroxysmal nocturnal hemoglobinuria.

  1996cites this paper
• Molecular Basis of Paroxysmal Nocturnal Hemoglobinuria

  1996cites this paper
• Syngeneic bone marrow transplantation without conditioning in a patient with paroxysmal nocturnal hemoglobinuria: in vivo evidence that the mutant stem cells have a survival advantage.

  1996cites this paper
• Applications of flow cytometry in transfusion medicine.

  1995cites this paper
• Clonal hematopoiesis as defined by polymorphic X-linked loci occurs infrequently in aplastic anemia.

  1995cites this paper
• Flow cytometric analysis of homologous restriction factor 20KD (HRF20) expression on progeny cells during differentiation from haemopoietic progenitors in paroxysmal nocturnal haemoglobinuria

  1995cites this paper
• A pathogenetic link between aplastic anemia and paroxysmal nocturnal hemoglobinuria is suggested by a high frequency of aplastic anemia patients with a deficiency of phosphatidylinositol glycan anchored proteins.

  1995cites this paper
• Defective glycosyl phosphatidylinositol anchor synthesis and paroxysmal nocturnal hemoglobinuria.

  1995cites this paper
• Flow cytometry related to red cells.

  1995cites this paper
• Paroxysmal nocturnal hemoglobinuria: New discoveries about an old disease

  1994cites this paper